Pfizer Is Dispensed From Billionaire Antitrust Process on Fixing Generic Drug Prices

Globo

Lean Right

Factuality

Ownership

Pfizer was dismissed as defendant in a wide antitrust process in which most states of the United States accused dozens of drug manufacturers and executives of setting generic drug prices, causing patients to pay more. In a decision on Tuesday (23), Michael Shea, chief judge of the Connecticut Federal District Court, said that the states failed to demonstrate that Pfizer and its former Greenstone unit conspired with rivals between 2010 and 2014 t…